Andreas Engert

Andreas Engert

UNVERIFIED PROFILE

Are you Andreas Engert?   Register this Author

Register author
Andreas Engert

Andreas Engert

Publications by authors named "Andreas Engert"

Are you Andreas Engert?   Register this Author

99Publications

2791Reads

7Profile Views

Reply to H.J.A. Adams et al.

J Clin Oncol 2020 Apr 30;38(10):1116-1117. Epub 2020 Jan 30.

Michael Fuchs, MD and Helen Goergen, Dipl-Math, German Hodgkin Study Group, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Carsten Kobe, MD, Department of Nuclear Medicine, University of Cologne, Cologne, Germany; and Peter Borchmann, MD, PhD and Andreas Engert, MD, German Hodgkin Study Group, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.03081DOI Listing
April 2020

Rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: long-term follow-up of a phase 2 study from the German Hodgkin Study Group.

Leukemia 2020 Mar 21;34(3):953-956. Epub 2019 Oct 21.

First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0609-3DOI Listing
March 2020

PET positivity - the agony of choice: response assessment and interpretation of increased FDG uptake of residual mediastinal tissue after frontline therapy in Hodgkin lymphoma.

Leuk Lymphoma 2020 Feb 16;61(2):251-254. Epub 2020 Jan 16.

German Hodgkin Study Group, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1711076DOI Listing
February 2020

Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies.

Cochrane Database Syst Rev 2020 01 13;1:CD012643. Epub 2020 Jan 13.

Faculty of Medicine and University Hospital Cologne, University of Cologne, Cochrane Cancer, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Kerpener Str. 62, Cologne, Germany, 50937.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD012643.pub3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984446PMC
January 2020

Volumetric assessment of mediastinal lymphoma masses in Hodgkin lymphoma.

Leuk Lymphoma 2019 12 22;60(13):3244-3250. Epub 2019 Jun 22.

Department of Radiation Oncology and Cyberknife Center, University Hospital of Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1623888DOI Listing
December 2019

Predictive Value of Positron Emission Tomography/Computed Tomography After ABVD-Based Chemotherapy in Early-Stage Hodgkin Lymphoma.

J Clin Oncol 2019 12 30;37(34):3324-3325. Epub 2019 Sep 30.

Carsten Kobe, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; Helen Goergen, Dipl-Math, Michael Fuchs, MD, and Horst Müller, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Christan Baues, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; Andreas Engert, MD, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Markus Dietlein, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; and Bastian von Tresckow, MD and Peter Borchmann, MD, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.01761DOI Listing
December 2019

Pretreatment Vitamin D Deficiency Is Associated With Impaired Progression-Free and Overall Survival in Hodgkin Lymphoma.

J Clin Oncol 2019 12 17;37(36):3528-3537. Epub 2019 Oct 17.

University of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German Hodgkin Study Group, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.00985DOI Listing
December 2019

The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma.

Am J Hematol 2019 11 21;94(11):1208-1213. Epub 2019 Aug 21.

First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25607DOI Listing
November 2019

Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9.

Authors:
Amand F Schmidt Michael V Holmes David Preiss Daniel I Swerdlow Spiros Denaxas Ghazaleh Fatemifar Rupert Faraway Chris Finan Dennis Valentine Zammy Fairhurst-Hunter Fernando Pires Hartwig Bernardo Lessa Horta Elina Hypponen Christine Power Max Moldovan Erik van Iperen Kees Hovingh Ilja Demuth Kristina Norman Elisabeth Steinhagen-Thiessen Juri Demuth Lars Bertram Christina M Lill Stefan Coassin Johann Willeit Stefan Kiechl Karin Willeit Dan Mason John Wright Richard Morris Goya Wanamethee Peter Whincup Yoav Ben-Shlomo Stela McLachlan Jackie F Price Mika Kivimaki Catherine Welch Adelaida Sanchez-Galvez Pedro Marques-Vidal Andrew Nicolaides Andrie G Panayiotou N Charlotte Onland-Moret Yvonne T van der Schouw Giuseppe Matullo Giovanni Fiorito Simonetta Guarrera Carlotta Sacerdote Nicholas J Wareham Claudia Langenberg Robert A Scott Jian'an Luan Martin Bobak Sofia Malyutina Andrzej Pająk Ruzena Kubinova Abdonas Tamosiunas Hynek Pikhart Niels Grarup Oluf Pedersen Torben Hansen Allan Linneberg Tine Jess Jackie Cooper Steve E Humphries Murray Brilliant Terrie Kitchner Hakon Hakonarson David S Carrell Catherine A McCarty Kirchner H Lester Eric B Larson David R Crosslin Mariza de Andrade Dan M Roden Joshua C Denny Cara Carty Stephen Hancock John Attia Elizabeth Holliday Rodney Scott Peter Schofield Martin O'Donnell Salim Yusuf Michael Chong Guillaume Pare Pim van der Harst M Abdullah Said Ruben N Eppinga Niek Verweij Harold Snieder Tim Christen D O Mook-Kanamori Stefan Gustafsson Lars Lind Erik Ingelsson Raha Pazoki Oscar Franco Albert Hofman Andre Uitterlinden Abbas Dehghan Alexander Teumer Sebastian Baumeister Marcus Dörr Markus M Lerch Uwe Völker Henry Völzke Joey Ward Jill P Pell Tom Meade Ingrid E Christophersen Anke H Maitland-van der Zee Ekaterina V Baranova Robin Young Ian Ford Archie Campbell Sandosh Padmanabhan Michiel L Bots Diederick E Grobbee Philippe Froguel Dorothée Thuillier Ronan Roussel Amélie Bonnefond Bertrand Cariou Melissa Smart Yanchun Bao Meena Kumari Anubha Mahajan Jemma C Hopewell Sudha Seshadri Caroline Dale Rui Providencia E Costa Paul M Ridker Daniel I Chasman Alex P Reiner Marylyn D Ritchie Leslie A Lange Alex J Cornish Sara E Dobbins Kari Hemminki Ben Kinnersley Marc Sanson Karim Labreche Matthias Simon Melissa Bondy Philip Law Helen Speedy James Allan Ni Li Molly Went Niels Weinhold Gareth Morgan Pieter Sonneveld Björn Nilsson Hartmut Goldschmidt Amit Sud Andreas Engert Markus Hansson Harry Hemingway Folkert W Asselbergs Riyaz S Patel Brendan J Keating Naveed Sattar Richard Houlston Juan P Casas Aroon D Hingorani

BMC Cardiovasc Disord 2019 10 29;19(1):240. Epub 2019 Oct 29.

Institute of Cardiovascular Science, University College London, 222 Euston Road, London, NW1 2DA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12872-019-1187-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820948PMC
October 2019

Introducing the HemaSphere Controversies Series.

Hemasphere 2019 Oct 27;3(5):e296. Epub 2019 Sep 27.

University of Cologne, First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HS9.0000000000000296DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919466PMC
October 2019

Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies.

Cochrane Database Syst Rev 2019 09 16;9:CD012643. Epub 2019 Sep 16.

University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cochrane Haematological Malignancies, Kerpener Str. 62, Cologne, Germany, 50937.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD012643.pub2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746624PMC
September 2019

Survivors' perspectives on risks and benefits of Hodgkin lymphoma treatment: results of a survey by the German Hodgkin Study Group.

Leuk Lymphoma 2019 06 3;60(6):1389-1398. Epub 2018 Dec 3.

a German Hodgkin Study Group (GHSG), Department of Internal Medicine I , University Hospital of Cologne , Cologne , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1540781DOI Listing
June 2019

Treatment of elderly Hodgkin lymphoma patients.

Authors:
Andreas Engert

Hematol Oncol 2019 Jun;37 Suppl 1:92-94

University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, GHSG, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2590DOI Listing
June 2019

Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies.

Cochrane Database Syst Rev 2020 01 13;1:CD012643. Epub 2020 Jan 13.

Faculty of Medicine and University Hospital Cologne, University of Cologne, Cochrane Cancer, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Kerpener Str. 62, Cologne, Germany, 50937.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD012643.pub3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984446PMC
January 2020

Symptomatic osteonecrosis as a treatment complication in Hodgkin lymphoma: an analysis of the German Hodgkin Study Group (GHSG).

Leukemia 2019 02 21;33(2):439-446. Epub 2018 Aug 21.

Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0240-8DOI Listing
February 2019

Programmed cell death protein-1 (PD-1)-expression in the microenvironment of classical Hodgkin lymphoma at relapse during anti-PD-1-treatment.

Haematologica 2019 01 3;104(1):e21-e24. Epub 2018 Aug 3.

Department of Pathology, Hematopathology Section, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.196279DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312019PMC
January 2019

Examining rare side effects in pooled trial data: symptomatic osteonecrosis in Hodgkin lymphoma.

Oncotarget 2018 Dec 25;9(101):37462-37463. Epub 2018 Dec 25.

Andreas Engert: Department of Internal Medicine and German Hodgkin Study Group, University Hospital of Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.26486DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331024PMC
December 2018

The First Year of HemaSphere and Many More to Come.

Hemasphere 2018 Dec 29;2(6):e161. Epub 2018 Nov 29.

VIB Center for Cancer Biology, KU Leuven Center for Human Genetics, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HS9.0000000000000161DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745960PMC
December 2018

Checkpoint Inhibition in Hodgkin Lymphoma - a Review.

Oncol Res Treat 2017 20;40(11):654-660. Epub 2017 Oct 20.

Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000481800DOI Listing
October 2018

Whole genome sequencing reveals DICER1 as a candidate predisposing gene in familial Hodgkin lymphoma.

Int J Cancer 2018 10 26;143(8):2076-2078. Epub 2018 Jul 26.

Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, Heidelberg, D-69120, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.31576DOI Listing
October 2018

Controversies in the Treatment of Classical Hodgkin Lymphoma.

Hemasphere 2018 Oct 2;2(5):e149. Epub 2018 Oct 2.

First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HS9.0000000000000149DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407792PMC
October 2018

Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.

J Clin Oncol 2018 09 10;36(25):2603-2611. Epub 2018 Jul 10.

Stephanie Sasse, Helen Goergen, Annette Plütschow, Boris Böll, Dennis A. Eichenauer, Michael Fuchs, Karolin Behringer, Christian Baues, Andreas Engert, Peter Borchmann, and Bastian von Tresckow, University Hospital of Cologne, Cologne; Max S. Topp, University Hospital of Würzburg, Würzburg; Julia Meissner, University of Heidelberg, Heidelberg; Andreas Neubauer, Philipps University, Marburg, Germany; Joseé M. Zijlstra, VU University Medical Center, Amsterdam, the Netherlands; Richard Greil, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute and Arbeitsgemeinschaft Medikamentöse Tumortherapie, Salzburg, Austria; and Jana Markova, Charles University in Prague and Faculty Hospital Kralovske Vinohrady, Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.7192DOI Listing
September 2018

Hodgkin lymphoma in elderly patients.

Curr Opin Oncol 2018 09;30(5):308-316

Department I of Internal Medicine, German Hodgkin Study Group (GHSG).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000464DOI Listing
September 2018

Hodgkin Lymphoma in Adults.

Dtsch Arztebl Int 2018 08;115(31-32):535-540

Joint first authors; Department I of Internal Medicine, University Hospital Cologne; German Hodgkin Study Group (GHSG), University Hospital Cologne; Evidence-based Oncology, University Hospital Cologne; German Guideline Program in Oncology of the German Cancer Society, Berlin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3238/arztebl.2018.0535DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131364PMC
August 2018

Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer).

Cochrane Database Syst Rev 2018 07 12;7:CD012556. Epub 2018 Jul 12.

Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Kerpener Str. 62, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD012556.pub2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513229PMC
July 2018

Leucocyte and eosinophil counts predict progression-free survival in relapsed or refractory classical Hodgkin Lymphoma patients treated with PD1 inhibition.

Br J Haematol 2018 06 25;181(6):837-840. Epub 2017 Apr 25.

German Hodgkin Study Group (GHSG), Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.14705
Publisher Site
http://dx.doi.org/10.1111/bjh.14705DOI Listing
June 2018

Hodgkin Lymphoma-Derived Extracellular Vesicles Change the Secretome of Fibroblasts Toward a CAF Phenotype.

Front Immunol 2018 18;9:1358. Epub 2018 Jun 18.

Clinic for Hematology, Oncology and Immunology, Experimental Tumor Research, Center for Tumor Biology and Immunology, Philipps University, Marburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2018.01358DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015880PMC
June 2018

Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial.

J Clin Oncol 2018 05 27;36(14):1428-1439. Epub 2018 Mar 27.

Philippe Armand and Margaret A. Shipp, Dana-Farber Cancer Institute, Boston, MA; Andreas Engert, University Hospital of Cologne, Cologne, Germany; Anas Younes, Memorial Sloan Kettering Cancer Center, New York, NY; Michelle Fanale, University of Texas MD Anderson Cancer Center, Houston, TX; Armando Santoro, Humanitas Cancer Center, Humanitas University, Milan; Pier Luigi Zinzani, Institute of Hematology "L. e A. Seràgnoli," University of Bologna, Bologna, Italy; John M. Timmerman, University of California Los Angeles Medical Center, Los Angeles, CA; Graham P. Collins, Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford, United Kingdom; Radhakrishnan Ramchandren, Barbara Ann Karmanos Cancer Institute, Detroit, MI; Jonathon B. Cohen, Winship Cancer Institute, Emory University, Atlanta, GA; Jan Paul De Boer, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands, on behalf of Lunenburg Lymphoma Phase I/II Consortium; John Kuruvilla, University of Toronto and Princess Margaret Cancer Centre, Toronto, Ontario; Kerry J. Savage, BC Cancer Agency, Vancouver, British Columbia, Canada; Marek Trneny, Charles University, General Hospital in Prague, Prague, Czech Republic; Kazunobu Kato, Anne Sumbul, and Benedetto Farsaci, Bristol-Myers Squibb, Princeton, NJ; and Stephen M. Ansell, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.0793DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075855PMC
May 2018

Balancing risk and benefit in early-stage classical Hodgkin lymphoma.

Blood 2018 04 2;131(15):1666-1678. Epub 2018 Mar 2.

Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-10-772665DOI Listing
April 2018

Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group.

Lancet Oncol 2017 12 10;18(12):1680-1687. Epub 2017 Nov 10.

First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group (GHSG), University Hospital of Cologne, Cologne, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30696-4DOI Listing
December 2017

Nodular lymphocyte-predominant Hodgkin lymphoma: a unique disease deserving unique management.

Hematology Am Soc Hematol Educ Program 2017 12;2017(1):324-328

First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2017.1.324DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142570PMC
December 2017

Hodgkin Lymphoma has a seasonal pattern of incidence and mortality that depends on latitude.

Sci Rep 2017 11 2;7(1):14903. Epub 2017 Nov 2.

German Hodgkin Study Group (GHSG), Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-017-14805-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668282PMC
November 2017

The evolving role of targeted drugs in the treatment of Hodgkin lymphoma.

Expert Rev Hematol 2017 09 10;10(9):775-782. Epub 2017 Jul 10.

a First Department of Internal Medicine , University Hospital Cologne , Cologne , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2017.1350167DOI Listing
September 2017

The genetics of Hodgkin lymphoma: an overview and clinical implications.

Curr Opin Oncol 2017 Sep;29(5):307-314

German Hodgkin Study Group (GHSG), Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000396DOI Listing
September 2017

Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.

Cochrane Database Syst Rev 2017 09 13;9:CD008814. Epub 2017 Sep 13.

Institute of Medical Statistics, Informatics and Epidemiology, University Hospital of Cologne, Kerpener Str. 62, Cologne, Germany, 50937.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD008814.pub2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483617PMC
September 2017

R-CHOP in NLPHL: who should receive it?

Blood 2017 07;130(4):387-388

UNIVERSITY HOSPITAL COLOGNE; GERMAN HODGKIN STUDY GROUP.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-05-786301DOI Listing
July 2017

Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials.

J Clin Oncol 2017 Jun 18;35(18):1999-2007. Epub 2017 Apr 18.

All authors: German Hodgkin Study Group (GHSG), Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.9410DOI Listing
June 2017

Late Relapse of Classical Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 Trials.

J Clin Oncol 2017 May 27;35(13):1444-1450. Epub 2017 Feb 27.

Paul J. Bröckelmann, Helen Goergen, Charlotte Kohnhorst, Bastian von Tresckow, Michael Fuchs, Peter Borchmann, and Andreas Engert, University Hospital of Cologne, Cologne; Julia Meissner, University of Heidelberg, Heidelberg; Andrea Kerkhoff, University Hospital of Münster, Münster; Wolf-Dieter Ludwig, Helios Kinikum Berlin-Buch, Berlin, Germany; Alden Moccia, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland; and Jana Markova, University Hospital Kralovske Vinohrady, Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.71.3289
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.71.3289DOI Listing
May 2017

Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.

Cochrane Database Syst Rev 2017 05 25;5:CD007941. Epub 2017 May 25.

Department I of Internal Medicine, University Hospital of Cologne, Kerpener Str. 62, Cologne, Germany, 50924.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD007941.pub3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481581PMC
May 2017

Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.

Cochrane Database Syst Rev 2017 04 27;4:CD007110. Epub 2017 Apr 27.

Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Kerpener Str. 62, Cologne, Germany, 50937.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD007110.pub3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478261PMC
April 2017

Evidence of Inbreeding in Hodgkin Lymphoma.

PLoS One 2016 28;11(4):e0154259. Epub 2016 Apr 28.

German Cancer Research Center (DKFZ), Division of Molecular Genetic Epidemiology (C050), Heidelberg, 69120, Germany.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0154259PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849743PMC
March 2017

Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuation.

Leuk Lymphoma 2017 01 17;58(1):222-225. Epub 2016 May 17.

a Department of Internal Medicine I, German Hodgkin Study Group (GHSG) , University Hospital of Cologne , Kerpener Str. 62 , Cologne , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1182164DOI Listing
January 2017

The emerging role of immune checkpoint inhibition in malignant lymphoma.

Haematologica 2017 01 24;102(1):30-42. Epub 2016 Nov 24.

Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne, Germany

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2016.150656DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210230PMC
January 2017

Reply to H.J.A. Adams et al, E.A. Hawkes et al, and C.F. Hess et al.

J Clin Oncol 2017 01 28;35(3):375-376. Epub 2016 Oct 28.

Peter Borchmann and Andreas Engert, University Hospital of Cologne and University of Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.7987DOI Listing
January 2017

Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration.

J Clin Oncol 2016 12 31;34(36):4329-4337. Epub 2016 Oct 31.

Karolin Behringer, Helen Goergen, Horst Müller, Indra Thielen, Corinne Brillant, Stefanie Kreissl, Michael Fuchs, Volker Diehl, Andreas Engert, and Peter Borchmann, University Hospital of Cologne; Jens Ulrich Rueffer, German Fatigue Society, Cologne; Teresa Veronika Halbsguth, University Hospital of Frankfurt, Frankfurt; Julia Meissner, University of Heidelberg, Heidelberg; Hans-Henning Flechtner, Otto von Guericke University, Magdeburg, Germany; Richard Greil, Paracelsus Medical University, Salzburg, Austria; Peter Moosmann, Cantonal Hospital Aarau AG, Aarau and Swiss Group for Clinical Cancer Research, Berne, Switzerland; and Oluwatoyin Shonukan, Boston University School of Public Health, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.7450DOI Listing
December 2016

Current and future immunotherapeutic approaches in Hodgkin lymphoma.

Leuk Lymphoma 2016 09 31;57(9):2014-24. Epub 2016 May 31.

a Department I of Internal Medicine and German Hodgkin Study Group (GHSG) , University Hospital of Cologne , Cologne , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1185789DOI Listing
September 2016

Current developments in the treatment of early-stage classical Hodgkin lymphoma.

Curr Opin Oncol 2016 09;28(5):377-83

German Hodgkin Study Group (GHSG), Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/co-oncology/2016/09000/Current_
Web Search
http://dx.doi.org/10.1097/CCO.0000000000000314DOI Listing
September 2016

Hodgkin lymphoma: Introduction.

Semin Hematol 2016 07 12;53(3):137-8. Epub 2016 May 12.

Department of Haematology, National and Kapodistrian University of Athens School of Medicine, Laikon General Hospital Athens, Greece. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2016.05.001DOI Listing
July 2016

Treatment of early-stage Hodgkin lymphoma.

Semin Hematol 2016 Jul 12;53(3):165-70. Epub 2016 May 12.

Department of Internal Medicine, Rijnstate Hospital, Arnhem, The Netherlands; Department of Hematology, Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2016.05.004DOI Listing
July 2016

Balancing the Risk-Benefit Ratio in the Treatment of Patients With Advanced-Stage Hodgkin Lymphoma.

J Clin Oncol 2016 06 11;34(17):1975-7. Epub 2016 Apr 11.

German Hodgkin Study Group; and University Hospital of Cologne, Cologne, Germany

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.3823DOI Listing
June 2016

PET-adapted omission of radiotherapy in early stage Hodgkin lymphoma-a systematic review and meta-analysis.

Crit Rev Oncol Hematol 2016 May 6;101:86-92. Epub 2016 Mar 6.

University Hospital of Cologne, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2016.03.005DOI Listing
May 2016

ABVD or BEACOPP for Advanced Hodgkin Lymphoma.

Authors:
Andreas Engert

J Clin Oncol 2016 Apr 28;34(11):1167-9. Epub 2015 Dec 28.

University Hospital of Cologne, Cologne, Germany

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.8683DOI Listing
April 2016

Granulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromes.

Cochrane Database Syst Rev 2016 Feb 16;2:CD009310. Epub 2016 Feb 16.

Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD009310.pub2DOI Listing
February 2016

What Is the Role of Rituximab in Nodular Lymphocyte-Predominant Hodgkin Lymphoma?

Acta Haematol 2015 27;134(3):185-6. Epub 2015 May 27.

First Department of Internal Medicine, and German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000381765DOI Listing
December 2015

Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy.

Cochrane Database Syst Rev 2015 Dec 21(12):CD007107. Epub 2015 Dec 21.

Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Kerpener Str. 62, Cologne, Germany, 50937.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD007107.pub3DOI Listing
December 2015

Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma.

Cochrane Database Syst Rev 2015 Oct 20(10):CD010615. Epub 2015 Oct 20.

Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD010615.pub2DOI Listing
October 2015

The GHSG Approach to Treating Hodgkin's Lymphoma.

Curr Hematol Malig Rep 2015 Sep;10(3):256-65

German Hodgkin Study Group (GHSG) and Department I of Internal Medicine, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-015-0262-5DOI Listing
September 2015

Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group.

J Clin Oncol 2015 Sep 3;33(26):2857-62. Epub 2015 Aug 3.

All authors: University Hospital Cologne, Cologne; and Hans Theodor Eich, University Hospital Münster, Münster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.4363DOI Listing
September 2015

XVII. Treatment of advanced-stage Hodgkin lymphoma.

Authors:
Andreas Engert

Hematol Oncol 2015 Jun;33 Suppl 1:87-9

University Hospital of Cologne, German Hodgkin Study Group (GHSG), Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2225DOI Listing
June 2015